Other research presented at the meeting found ARBs reduce the risk for epilepsy in patients with hypertension even in the absence of stroke. Using data from an US national administrative database ...

Angiotensin receptor blockers (ARBs) were found to be equally effective to angiotensin-converting enzyme (ACE) inhibitors for first-line treatment of hypertension; however ARBS may be less likely ...

If included in National List of Essential Medicines (NLEM), the fixed-dose combinations (FDCs) to rein in hypertension can be ...

A class of drugs already used to treat high blood pressure has an added bonus, according to a new study: lowering epilepsy risk by up to 30%. Further research is needed, but the findings suggest ...

Hypertension was associated with the risk for severe COVID-19 and use of angiotensin-converting enzyme inhibitors (ACEi) or angiotensin-II receptor blockers (ARB) did not mitigate the associated risk.

ARBs may offer advantages over other blood pressure medications for cognitive protection because they don’t affect bradykinin levels, which could theoretically provide better brain protection.

They enrolled 107,207 patients with newly diagnosed hypertension from the Taiwan National Health Insurance Research Dataset between 2001 and 2013 to compare the PD risk with ARB treatment users (n ...

The age-adjusted prevalence of hypertension among U.S. adults aged 18 years and older was recently found to be 29.1% in 2011-2012. 1 Prevalence increased with age, from 7.3% in persons aged 18 to ...

Telmisartan shows more advantages than other ARBs for people with diabetes (T2D) and chronic kidney disease (CKD) as well as hypertension. Further, animal studies indicate that this drug may help ...